These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3966596)

  • 1. Reinstitution of diet therapy in PKU patients from twenty-two US clinics.
    Schuett VE; Brown ES; Michals K
    Am J Public Health; 1985 Jan; 75(1):39-42. PubMed ID: 3966596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
    Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
    Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet policies of PKU clinics in the United States.
    Schuett VE; Brown ES
    Am J Public Health; 1984 May; 74(5):501-3. PubMed ID: 6711729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood phenylalanine levels and intelligence of 10-year-old children with PKU in the National Collaborative Study.
    Michals K; Azen C; Acosta P; Koch R; Matalon R
    J Am Diet Assoc; 1988 Oct; 88(10):1226-9. PubMed ID: 3171015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on the effects of diet discontinuation in PKU.
    Koch R; Azen CG; Friedman EG; Williamson ML
    J Pediatr; 1982 Jun; 100(6):870-5. PubMed ID: 7086586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life.
    Waisbren SE; Mahon BE; Schnell RR; Levy HL
    Pediatrics; 1987 Mar; 79(3):351-5. PubMed ID: 3822635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J; Fromm J; van Teeffelen-Heithoff A; Möller HE; Koletzko B; Marquardt T; Rutsch F; Feldmann R
    Mol Genet Metab; 2013; 110 Suppl():S44-8. PubMed ID: 24071437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
    Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
    Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction.
    Seashore MR; Friedman E; Novelly RA; Bapat V
    Pediatrics; 1985 Feb; 75(2):226-32. PubMed ID: 3969322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental development of phenylketonuric children on or off diet after the age of six.
    Brown ES; Warner R
    Psychol Med; 1976 May; 6(2):287-96. PubMed ID: 63976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related working memory impairments in children with prefrontal dysfunction associated with phenylketonuria.
    White DA; Nortz MJ; Mandernach T; Huntington K; Steiner RD
    J Int Neuropsychol Soc; 2002 Jan; 8(1):1-11. PubMed ID: 11843066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors.
    Wappner R; Cho S; Kronmal RA; Schuett V; Seashore MR
    Pediatrics; 1999 Dec; 104(6):e68. PubMed ID: 10586002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A; Palasti F; Juhasz E; Kiss E; Simonova E; Sumanszki C; Reismann P
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].
    Schwarz HP; Plüss C; Triaca H; Schütz B; Kaufmann R; Scherz R; Bachmann C; Zuppinger K
    Schweiz Med Wochenschr; 1988 Jan; 118(3):94-9. PubMed ID: 3344414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria and its variants: observations on intellectual functioning.
    Netley C; Hanley WB; Rudner HL
    Can Med Assoc J; 1984 Oct; 131(7):751-5. PubMed ID: 6478363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria.
    Holtzman NA; Kronmal RA; van Doorninck W; Azen C; Koch R
    N Engl J Med; 1986 Mar; 314(10):593-8. PubMed ID: 3945244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social quotients of children with phenylketonuria before and after discontinuation of dietary therapy.
    Matthews WS; Barabas G; Cusack E; Ferrari M
    Am J Ment Defic; 1986 Jul; 91(1):92-4. PubMed ID: 3740120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new, low-volume protein substitute for teenagers and adults with phenylketonuria.
    MacDonald A; Lilburn M; Cochrane B; Davies P; Daly A; Asplin D; Hall SK; Cousins A; Chakrapani A; Robinson P; Lee P
    J Inherit Metab Dis; 2004; 27(2):127-35. PubMed ID: 15159643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitory hyperphenylalaninaemia in children with continuously treated phenylketonuria.
    Griffiths P; Smith C; Harvie A
    Am J Ment Retard; 1997 Jul; 102(1):27-36. PubMed ID: 9241405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.